Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
67 results about "Pyloric orifice" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
The pyloric canal ends as the pyloric orifice, which marks the junction between the stomach and the duodenum. The orifice is surrounded by a sphincter, a band of muscle, called the pyloric sphincter. The word pylorus comes from Greek πυλωρός, via Latin.
Methods of treatment using a bariatric sleeve
ActiveUS7695446B2Promote healingControlled absorptionSuture equipmentsStentsDiseaseIntestinal structure
Methods of treatment using a gastrointestinal implant device removably anchored within an animal's gastrointestinal tract. For example, the implant device includes a collapsible anchor for anchoring the device coupled to a proximal end of a flexible sleeve. The implant device can be anchored within the stomach, within the pyloric orifice, and / or distal to the pylorus and extended into the duodenum. All partially-digested food, or chyme, exiting the stomach is funneled through the device. Methods of treatment include treating obesity by one or more of: limiting the absorption of nutrients within the duodenum; delaying the mixing of chyme with digestive enzymes; alter hormonal triggers; and providing negative feedback. Alternatively or in addition, the desired result includes treating a diseases, such as diabetes, or temporarily shielding a portion of the intestine to promote healing within the intestine.
Owner:GI DYNAMICS INC
Obesity treatment tools and methods
Various obesity treatment tools and methods are described herein, as well as treatments for other gastric-related diseases, e.g., GERD. Treatment includes reducing the size of the stomach pouch to limit the caloric intake as well as to provide an earlier feeling of satiety. This may be done by creating a smaller gastric pouch within the stomach directly from the interior of the stomach itself. The smaller pouches may be made through the use of individual anchoring devices, rotating probes, or volume reduction devices. A pyloroplasty procedure may also be performed to render the pyloric sphincter incompetent. A gastric bypass procedure may additionally be performed using atraumatic magnetic anastomoses devices so that sugars and fats are passed directly to the bowel while bypassing the stomach. Many of these procedures may be done in a variety of combinations. Treatment may create enforced behavioral modifications by discouraging the ingestion of high-caloric foods.
Owner:ETHICON ENDO SURGERY INC
Medical Device and Method For Controlling Obesity
InactiveUS20080249533A1Slow down passage of foodEat more slowlyEar treatmentOesophagiPyloric orificeDiaphragm muscle
A method of, and device for, slowing the passage of food through a digestive tract of a patient and thereby treating obesity. The device is an obesity tube comprising (A) an upper ring of a size corresponding to a point under a patient's esophagus and above the patient's diaphragm muscle, and (B) a lower tube having a length and a distal opening. The method comprises stapling the upper ring under the patient's esophagus, above the patient's diaphragm muscle, and placing the lower tube distal to the upper ring. The length of the lower tube depends on whether the tube is to terminate distally in the stomach or terminate past the pylorus, in which case a section can be provided which is thick enough to resist collapsing under pylorus pressure. The lower tube can be entirely or partially non-permeable or semi-permeable. Semi-permeable tubes or sections thereof have walls which permit the passage of gastric hydrochloric acid but not food.
Owner:KS BIOMEDIX LTD
Ingestible formulations for transient, noninvasive reduction of gastric volume
Provided are ingestible polymeric formulations and oral dosage forms for the reduction of gastric volume in the treatment of overweight and obese patients. The formulation includes an acid-sensitive, gelatin coating over a dehydrated hydrophilic polymer. When ingested, the acid-sensitive coating is quickly dissolved by gastric secretions and the hydrophilic polymer is exposed to the aqueous environment of the gastric milieu. The polymer absorbs water and expands to the point that will not allow the polymer to pass beyond the pyloric valve, and the expanded polymer is therefore trapped in the stomach.
Owner:BARONOVA
Systems and methods for treating obesity and other gastrointestinal conditions
InactiveUS20090118699A1Reduce morbidityIncrease satietyElectrotherapyPeptide/protein ingredientsReflexREFLEX DECREASE
Systems and methods affect tightening of the pyloric sphincter and / or serve to mediate or moderate receptive relaxation of muscles in the stomach, to treat or mitigate various physiologic conditions, such as obesity, biliary reflex, GERD, and / or Barrett's esophagus. The systems and methods may be used as either a primary treatment modality, or applied as a supplementary treatment before, during or after a primary intervention.
Owner:RESPIRATORY DIAGNOSTICS
Sustained release methotrexate formulations and methods of use thereof
InactiveUS20080268045A1Reduce morbidityGood curative effectBiocideSkeletal disorderDiseaseOral medication
Described herein are methods of treating a disease by treatment with oral sustained release methotrexate alone or in combination with folates. In some embodiments, these approaches improve the pharmacotherapeutic performance of methotrexate therapy.Described herein are novel pharmaceutical compositions for oral administration. Also described herein are novel pharmaceutical compositions for the controlled, sustained delivery of one or more drugs to the stomach or upper gastrointestinal tract. Further described are novel pharmaceutical compositions with increased gastrointestinal residence time. More particularly, novel pharmaceutical compositions which can simultaneously, float in gastric fluid, adhere to the mucosal surfaces of the gastrointestinal tract, swell to a size which delays passage through the pylorus, are described herein. In some embodiments, the pharmaceutical compositions comprise methotrexate. In some embodiments, the pharmaceutical compositions comprise methotrexate and a folate compound. Also described herein are methods for treating or preventing diseases, by administration of the pharmaceutical compositions described herein.
Owner:CYPRESS BIOSCI
Chinese medicinal composition for treating gastropathy and method of preparing the same
The invention relates to a traditional Chinese medicine combination for curing gastric diseases and a preparation method thereof, which solve the problem that the original traditional Chinese combinations for curing gastric diseases do not have prominent effects and have high recurrence rate. The medicine combination is prepared by corydalis tuber, Chinaberry fruit, turmeric root tuber, evodia rutaecarpa, coptis chinensis, villous amomum fruit, costus root, radix linderae, rhizoma cyperi, frankincense, myrrh and cuttlebone. The traditional Chinese medicine combination has the functions of soothing the liver and regulating vital energy, removing heat from the liver, promoting blood circulation to arrest pain, promoting wound healing and granulation, and can be used for curing gastric and duodenal ulcer, gastritis, stomachache, salivation and sour regurgitation, nausea, retching, epigastric distension and depression; besides, the traditional Chinese combination has special curative effects on gastric ulcer and duodenal ulcer and has inhibiting effect on helicobacter pylori.
Owner:四川抗菌素工业研究所有限公司
Methods for treatment of Helicobacter pylori-associated disorders
InactiveUS7271146B2Mitigate/eliminate bacterial componentAntibacterial agentsBiocideDiseaseHelicobacter
The present invention relates to methods for treating pathological conditions associated with Helicobacter sp infections, specifically H. pylori infection. The present invention further relates to methods for treating pathologies characterized by excess gastric acid secretion. The methods of the present invention comprise oral administration of pentagastrin effective locally in the stomach in conjunction with a gastric proton pump inhibitor. It is disclosed herein for the first time that PG administered orally exerts a local effect in the stomach and may be used in combination with a PPI for treating pathological conditions characterized by excess gastric acid secretion and in pathological conditions associated with Helicobacter sp infections.
Owner:VECTA
Bypass device for the transpyloric conducting of gastric content into or through the duodenum, and applicator for putting same in place
The invention relates to a transpyloric device for accepting chyme from the stomach and conducting said chyme on in a bypass-like manner through a patient's duodenum; said device is held in place by balloon segments which sit on a preferably radially collapsible and self-erecting transpyloric conducting element; the filling level of the balloon segments, and thus the axial sealing force acting primarily on the shoulder surfaces of the pylorus or the surrounding area thereof, can be adjusted by the user, and the force applied to the stomach and duodenum structures adjoining the pylorus is reduced to a level that is permanently bearable for the organs even when the filling pressure of the segments rolling against each other is elevated. The invention also relates to an applicator for putting a bypass device of said type in place in the region of the transition from the stomach to the duodenum.
Owner:TRANS DUODENAL CONCEPTS UG
Experimental device for automatic simulation of gastrointestinal continuous digestion and application method
PendingCN110231437AStable pHReal-time monitoring of particle size changesMaterial analysisPylorusPh regulation
The invention provides a device capable of realizing automatic simulation of gastrointestinal continuous digestion and an application method of the device. The device comprises a stomach reactor, a stirrer, a constant-temperature water circulation system, a gastrointestinal fluid conveying system, a gastric emptying control device, an automatic pH titration device, a small intestine reactor and asample receiving device. According to the application method, to-be-digested food is conveyed into a stomach digester, stomach digestive fluid is input at a constant speed, the stirrer simulates stomach peristalsis, a micropore glass plate at the bottom of the stomach reactor simulates a pylorus to realize stomach "sieving emptying", the to-be-digested food is conveyed into a pH regulation chamberfor automatic pH regulation, small intestine digestion is simulated in the small intestine reactor provided with an internally-arranged latex sleeve, and the pressure-changing water circulation system is adopted to realize regular vibration of the latex sleeve so as to simulate the stomach peristalsis. Through the device and the application method, the whole reaction process can be continuous andautomatic under the situation that parameters are set; and moreover, the device is simple in structure, free of a complicated control system and easy to assemble and can be used to realize a digestion simulation experiment in a scientific research experiment.
Owner:HEFEI UNIV OF TECH
Use of heliocbacter pylori extract for treating or preventing inflammatory bowel diseases and coeliac disease
The present invention is directed to polypeptides and compositions thereof useful for the prevention or treatment of an inflammatory bowel disease in particular Crohn's disease or ulcerative colitis (UC), and of coeliac disease. More particularly, the invention relates to agents and compositions thereof that useful for the prevention and treatment of hypersensitivity and / or hyperirritability of the colon and / or small intestine.
Owner:UNIV ZURICH
Polyol-amino acid compounds having anti-helicobacter pylori activity
A compound of the formula (I):wherein R1 represents an amino group which may be substituted; R2 represents a carboxy group which may be esterified or amidated; R3, R4, R5 and R6 each represent a hydroxy group which may be protected; Q represents an aryl group which may be substituted; or a salt thereof is disclosed. The compound (I) possesses ant-Helicobacter pylori activity, and is useful in the prevention or treatment of various diseases associated with Helicobacter bacteria, such as duodenal ulcer, gastric ulcer, chronic gastritis and cancer of the stomach.
Owner:TAKEDA PHARMA CO LTD
Bypass device for the transpyloric conducting of gastric content into or through the duodenum, and applicator for putting same in place
The invention relates to a transpyloric device for accepting chyme from the stomach and conducting said chyme on in a bypass-like manner through a patient's duodenum; said device is held in place by balloon segments which sit on a preferably radially collapsible and self-erecting transpyloric conducting element; the filling level of the balloon segments, and thus the axial sealing force acting primarily on the shoulder surfaces of the pylorus or the surrounding area thereof, can be adjusted by the user, and the force applied to the stomach and duodenum structures adjoining the pylorus is reduced to a level that is permanently bearable for the organs even when the filling pressure of the segments rolling against each other is elevated. The invention also relates to an applicator for putting a bypass device of said type in place in the region of the transition from the stomach to the duodenum.
Owner:TRANS DUODENAL CONCEPTS UG
Chinese medicinal composition for treating stomach and duodenal ulcer and preparation
ActiveCN101214337AObvious bactericidalObvious bacteriostasisPowder deliveryDigestive systemDuodenal ulcerMucosal lesion
The present invention provides a Chinese medicine compound for curing gastric and duodenal ulcer, made from the raw materials with weight portions such as yanhusuo, dandelion, nutgrass flastedge, mastic gum, alum and liquorice, and a preparation method of capsule, tablet, pill, granule, powder, dropping pill and oral liquid of the compound. The present invention has the functions of obvious sterilization and bacteriostasis on helicobacter pylori, reduction of gastric juice amount, gastric free acid and total acidity, and pepsin output, as well as pain alleviating and inflammation resisting, so the present invention has the functions of inhibiting stress type, ostium pyloricum deligation, acetic acid and ethanol ulcer, as well as pain alleviating and inflammation resisting. In addition, the present invention can reduce the stimulus factors of chronic gastricism, gastric ulcer and gastratrophia lesions, improve the symptoms of patients with gastric ulcer and play a promoting role in repairing and improving gastric mucosal lesion.
Owner:青岛华仁太医药业有限公司
Pyloric state detection system applying signal analysis
InactiveCN111839439AKnot operation is simpleDiagnostic signal processingGastroscopesAnomaly detectionPyloric orifice
The invention relates to a pyloric state detection system applying signal analysis, and the system comprises a content extraction mechanism which is used for calculating the entity area of a pyloric target based on a received photographing focal length, the overall depth of field, and the number of reference pixels; a radius identification equipment which is connected with a content extraction mechanism and is used for calculating the radial radius of the pyloric target based on the shape of the to-be-analyzed region corresponding to the pyloric target and the entity area of the pyloric target; and an anomaly detection mechanism which is connected with the radius identification equipment and is used for sending a pylorus anomaly instruction when the absolute value of the difference value between the maximum radial radius and the standard pylorus radius exceeds a limit. The pyloric state detection system applying signal analysis is simple to operate and wide in application. The targetedrecognition mode can be adopted to perform recognition operation on the pylorus radius of the patient according to the pylorus shape of the current patient and the pylorus entity area of the currentpatient, whether the pylorus of the current patient is in a diseased state or not can be judged.
Owner:朱来清
Hericium erinaceus beverage capable of invigorating stomach and nourishing stomach and preparation method of hericium erinaceus beverage
InactiveCN105707618AHas the effect of nourishing the stomachFully develop the applicationFood preparationPyloric orificeDuodenal ulcer
The invention relates to a hericium erinaceus beverage capable of invigorating the stomach and nourishing the stomach, and a preparation method of the hericium erinaceus beverage, wherein the hericium erinaceus beverage is prepared from 0.1%-15% of hericium erinaceus as a raw material component. The hericium erinaceus beverage is good in quality, color and mouth feel, free from color brown stains, clear and transparent in liquid, free from mushroom flesh precipitation, and free from flavor changes; the hericium erinaceus beverage has the efficacies of repairing gastric mucosa damage caused by chronic gastritis, gastric ulcers or duodenal ulcers, alleviating abdomen pains caused by the chronic gastritis, the gastric ulcers or the duodenal ulcers, being capable of performing auxiliary treatment on the chronic gastritis, the gastric ulcers and the duodenal ulcers, and restraining helicobacter pylori, and is suitable for crowds suffering from gastric diseases (the chronic gastritis, the gastric ulcers and the duodenal ulcers) to drink.
Owner:JIANGXI JIANGZHONG DIETOTHERAPY TECH CO LTD
Preparation for preventing and treating helicobacter pylori
PendingCN112353935AHigh selectivityTo achieve the same appetiteAntibacterial agentsOrganic active ingredientsPyloric orificePoly d lysine
The invention provides a helicobacter pylori preparation capable of preventing and treating oral cavity and stomach, the helicobacter pylori preparation adopts lactoferrin and polylysine for compatibility, the adopted dosage form is spray, through research on the compatibility, the killing effect on helicobacter pylori people can be greatly improved, and the helicobacter pylori preparation can beused for preventing and treating oral cavity and stomach diseases. Meanwhile, the spray dosage form can kill oral helicobacter pylori, and the preparation can reach the stomach by swallowing drinkingwater and the like, so that the helicobacter pylori in the stomach can be killed in an auxiliary manner.
Owner:南京康容健康科技有限公司
Chinese herbal medicine for treating raccoon pyloric duodenal ulcer and gastric perforation
InactiveCN103142855APromote secretionRegulates phagocytosisPowder deliveryDigestive systemBletilla striataPyloric orifice
The invention relates to a Chinese herbal medicine for treating raccoon pyloric duodenal ulcer and gastric perforation. The Chinese herbal medicine is powder prepared from the following raw materials in parts by weight: 4-6 parts of licorice roots, 2-4 parts of forged concha arcae, 2-4 parts of fried cuttlebone, 0.5-1 part of bletilla, 1-2 parts of rhizoma corydalis, 2-3 parts of costus roots, 2-4 parts of baical skullcap roots, 1-2 parts of Chinese rhubarb and 0.5-1 part of henbane. The Chinese herbal medicine is used for treating raccoon pyloric duodenal ulcer and gastric perforation, and has the characteristics of short course of treatment, low cost, high curing rate, security and no toxic and side effect, and is convenient for orally taking.
Owner:HEBEI NORMAL UNIVERSITY OF SCIENCE AND TECHNOLOGY
Inflatable visual stomach tube traction device
PendingCN111921069AInflatable structure is simpleLow processing and manufacturing costsBalloon catheterGastroscopesPyloric orificeSmall intestine
The invention discloses an inflatable visual stomach tube traction device, and belongs to the field of medical instruments. Generally, for a non-surgical patient, bare-handed application of the gastrointestinal tube can only reach the stomach, the gastrointestinal tube is difficult to enter the small intestine through pylorus, and the gastrointestinal tube easily gets stuck when touching the bottom gastric varus area. The inflatable visual stomach tube traction device is characterized in that an air bag strap (3) is sleeved outside a combined guide air bag (2), the combined guide air bag (2) is fixedly connected with a sealing plug (4), the other end of the sealing plug (4) is sleeved with a sleeve (5), and the outer wall of the sleeve (5) is sleeved with a stomach tube (6); an endoscope (1) sequentially penetrates through the stomach tube (6), the sleeve (5), the sealing plug (4) and the combined guide air bag (2), and a camera is installed at the front end of the endoscope (1); and agroup of inflating pipes (7) are uniformly arranged at the periphery of the endoscope (1). The stomach tube traction device can bend and rotate, the degree of freedom is more flexible, and bending, twisting, rotating and other operations can be achieved through the control quantity of gas in different channels.
Owner:WUXI NO 2 PEOPLES HOSPITAL
Composition with auxiliary protection effect on gastric mucosal injury and application
PendingCN112641097AImprove or protect healthAvoid damageAntibacterial agentsDigestive systemEpitheliumPyloric orifice
The invention provides a composition with an auxiliary protection effect on gastric mucosal injury and application, and relates to the technical field of health care products. The composition comprises the following components in parts by weight of 30-60 parts of a water extract of hericium erinaceus sporocarp, 18-40 parts of a poria cocos water extract, 2-8 parts of a liquorice water extract and 10-25 parts of an astragalus membranaceus water extract. The composition disclosed by the invention can relieve gastric mucosal injury, and the inhibition rate can reach 40-67.5% under medium-concentration and high-concentration doses; the composition has the effects of protecting gastric mucosa epithelium from being damaged by ethanol and preventing ulcer; and the composition has a certain inhibition effect on helicobacter pylori. The composition disclosed by the invention has an obvious protective effect on ethanol-induced gastric mucosal acute injury, also has a good antibacterial effect on helicobacter pylori, is pleasant in taste, does not need to be added with seasoning auxiliary materials, and can be used for improving or protecting gastric mucosal health.
Owner:山西康欣药业有限公司
Helicobacter pylori stomach video full-automatic intelligent analysis system and marking method thereof
PendingCN114359131AReal-time judgment of infectionFully automatedImage analysisCharacter and pattern recognitionPyloric orificeHelicobacter Infections
The invention belongs to the field of medical data mining, and particularly relates to a helicobacter pylori stomach video full-automatic intelligent analysis system and a marking method thereof.The helicobacter pylori stomach video full-automatic intelligent analysis system comprises an image acquisition module, an image preprocessing module, an effective frame module, an anatomical position positioning module, a deep learning module and a mark display module; the image preprocessing module is used for preprocessing images of a video stream, the effective frame module is used for classifying and screening the images of the video stream, and the anatomical position positioning module is used for identifying the specific position of an endoscope in the stomach currently. And the deep learning module is used for predicting the helicobacter pylori infection probability for the pictures of different anatomical positions. In the testing process, a doctor does not need to step on a pedal to input a specific picture for helicobacter pylori infection recognition, manual intervention is not needed in the whole process, and full automation and high intelligence can be achieved.
Owner:ZHEJIANG UNIV
Medicinal preparation for preventing from pyloric helicobacterium inflammation
InactiveCN1552445ANo cross reactionStrong immunostimulatory effectPeptide/protein ingredientsDigestive systemAntigenNasal cavity
A medicine for preventing the infection of pylorospirobacillus is prepared from 3 kinds of antigen protein and CpG-ODN through dissolving them in aseptic distilled water at 4 deg.C and mixing. It is applied by dropping it in nasal cavity.
Owner:RENJI HOSPITAL ATTACHED TO SHANGHAI NO 2 MEDICALUNIV
Application of andrographolide
ActiveCN104116732AGood curative effectInhibit Helicobacter pyloriAntibacterial agentsOrganic active ingredientsSide effectHelicobacter
The invention discloses application of andrographolide, and belongs to the field of medicine application. The medicine is used to protect gastric mucosa, is capable of mitigating gastric mucosal injury caused by drinking, helicobacter pylori and abnormal gastric acid secretion, is suitable for long-term administration, and has no obvious side effect.
Owner:SHIJIAZHUANG YILING PHARMA
Flanged gastrointestinal devices and methods of use thereof
The present invention provides gastrointestinal devices for limiting transfer and contact of material across luminal walls along a segment of the gastrointestinal tract (e.g., at the duodenum and / or upper jejunum). Devices of the invention include a gastrointestinal sleeve, an anchor, and a flange for attachment to a luminal wall proximal to the pyloric orifice. The invention also provides methods of use associated with such gastrointestinal devices, including methods for delivery, removal, and treatment of metabolic disorders, such as type 2 diabetes, non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, obesity, and related comorbidities thereof by implanting gastrointestinal devices.
Owner:GI DYNAMICS
Traditional Chinese medicine used for treating gastrosis and preparation method thereof
ActiveCN102973765AInhibit gastric secretionReduce dischargeDigestive systemMammal material medical ingredientsSpecial effectsTraditional Chinese medicine
The invention provides a traditional Chinese medicine used for treating gastrosis and a preparation method thereof. The traditional Chinese medicine comprises, by weight, 1 part of gizzard lining and 0.2 part of aloe powder. The preparation method includes the following steps: (1) removing impurities of the gizzard lining, soaking with water for 24-36 hours, taking the gizzard lining and cleaning, (2) drying the cleaned gizzard lining, frying slowly until the gizzard lining is plump, taking the gizzard lining out, adding the aloe powder rapidly, evenly mixing, sealing and storing for 24-48 hours, and smashing to obtain the traditional Chinese medicine used for treating the gastrosis. By means of the gizzard lining soaked with the aloe, the traditional Chinese medicine used for treating the gastrosis has large astringent and healing effects on stomach inflammation and ulcer cambiums. Besides, odor of the gizzard lining is removed, so special effects such as inflammation prevention, sterilization and stomach fortifying are enhanced. The medicine further has a function of inhibiting helicobacter pylori, and therefore treatment effects are remarkable. The traditional Chinese medicine is remarkable in treatment effect, safe, and efficient. Cure efficiency is 96.4%.
Owner:YICHANG CITY JIULING INST OF TRADITIONAL CHINESE MEDICINE
Therapeutic agents and treatment kits for hypertrophic pyloric stenosis
InactiveUS20040086536A1Nitro compound active ingredientsDigestive systemAnticholinergic agentsPyloric orifice
Hypertrophic pyloric stenosis can be treated by suppressing contraction of the pyloric muscle by using a therapeutic agent or a treatment kit which comprises atropine sulfate as an anticholinergic agent and nitroglycerin or isosorbide nitrate as an NO donor as the active ingredients.
Owner:EISIA R&D MANAGEMENT CO LTD
Multifunctional gastric lavage model and gastric lavage training method
ActiveCN112562472AEasy to observeEasy diagnosisCosmonautic condition simulationsEducational modelsStomach partPyloric orifice
The invention discloses a multifunctional gastric lavage model and a gastric lavage training method, and belongs to the technical field of medical teaching supplies, the multifunctional gastric lavagemodel comprises an upper body model and a toxic object, the upper body model comprises a head and an upper body part, an esophagus is arranged in an accommodating cavity of the upper body part, one end of the esophagus is communicated with a nasal cavity, and a stomach comprises a transparent elastic layer and a transparent silica gel layer; the stomach is fixed in the accommodating cavity through a first fixing assembly, a stomach cavity communicated with a cardia and a pylorus is formed in the stomach, and the cardia is communicated with the other end of the esophagus; after a stomach tubeis inserted into the stomach cavity through the nasal cavity and the esophagus, liquid can be injected into or sucked out of the stomach cavity through the stomach tube, and when the liquid is suckedthrough the stomach tube, the toxic object can be sucked out of the upper body model from the stomach cavity along with the liquid. The gastric lavage training method is also disclosed. According to the multifunctional gastric lavage model and the gastric lavage training method, intubation and extraction operations can be practiced, and liquid injection and extraction operations can be completed,so that an operator can simulate complete gastric lavage operation.
Owner:HEBEI UNIV OF CHINESE MEDICINE
Composition for protecting gastric mucosa, nourishing stomach and protecting stomach and preparation method thereof
ActiveCN102397524BReduce secretionPromote secretionAntibacterial agentsDigestive systemPyloric orificeGastric pepsin
The invention discloses a composition for protecting gastric mucosa, nourishing stomach and protecting the stomach. The composition comprises the following raw materials in part by weight: 60-98 parts of seabuckthorm seed oil and 2-40 parts of wild ginger oil. The invention has the beneficial effects that: (1) the composition disclosed by the invention has the effects of reducing gastric acid secretion, lowering pepsin activity, increasing gastric mucus secretion, enhancing gastric motility, killing helicobacter pylori, protecting the stomach, sterilizing, warming the stomach and nourishing the stomach; (2) the seabuckthorm seed oil and the wild ginger oil serving as raw materials used in the invention have synergic actions, so that the treatment and prevention effects of the two raw materials which are taken separately on the stomach are improved; (3) the composition is safe and free from side effects; and (4) the problem that a patient suffering from stomach diseases is required to take antibiotics and various medicaments for suppressing gastric acid secretion, increasing gastric motility and the like is solved, the dosage of the patient is reduced greatly, and the mental pressure of the patient is also relieved.
Owner:宝健(北京)生物技术有限公司
Capsule for treating gastritis
The invention relates to a capsule for treating gastritis. The capsule or pill prepared from traditional Chinese medicines is used for treating chronic superficial gastritis caused by helicobacter pylori infection and other causes. Chinese patent medicines (including capsules and pills) prepared from Chinese herbal medicines are used for oral medication. According to the theory of western medicine, the chronic superficial gastritis is treated according to ulcers, so that the capsule can also be used for treating gastric ulcer. The capsule provided by the invention adopts a medicine integratingthe functions of strengthening the middle warmer, tonifying Qi and strengthening spleen, regulating Qi and harmonizing stomach, clearing away heat and toxic materials, resisting bacteria and diminishing inflammation, cooling blood and promoting blood circulation to remove blood stasis to inhibit and kill HP growth and promote inflammation resolution and ulcer healing.
Owner:梁允晖
Use of chloride 13-hexyl berberine in preparation of medicine for treating peptic ulcer and bacteriological gastroenteritis
The invention relates to a method for using alcaine 13-hexyl berberine to prepare the drug that treats gastritis enteritis caused by pylorus bacillus (Hp), etc. Wherein, alcaine 13-hexyl berberine is the derivate replaced by replacing the thirteenth -H with hexyl -C6H13 in parent compound alcaine berberine, its MIC resistant to pylorus bacillus is 2 mug / ml, and anti-inflammatory cell factor is IC505-10 mug / ml. It has stronger activity then alcaine berberine. And it can be made into oral tablet and capsule.
Owner:CHUGOKU IGAKU KAGAKUIN HIFUBIYOU KENKYUSHO
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap